SWARTZ ROBIN (Chief Operating Officer) sold 3.8% of their position (3.89K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2025ACC: 0001104659-25-016516
Officer· Chief Operating Officer
Since Feb 2022
+209.86K
Net shares
Net buyer
$16.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
213.75K acquired · 3.89K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.89K
Price / share
$4.25
Trade value
$16.55K
% of position
3.8%
2/20/2025
102.29K→98.40K
Common Stock
Direct
Shares
+71.25K
Price / share
—
Trade value
—
% of position
72.4%
2/21/2025
98.40K→169.65K
Total
Net shares
+67.36K
Net value
-$16.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2025 | S · Sale | −3.89K | $4.25 | $16.55K | 3.8% | 102.29K | 98.40K |
| Common Stock Direct | 2/21/2025 | A · Award | +71.25K | — | — | 72.4% | 98.40K | 169.65K |
| Total | +67.36K | -$16.55K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
142.50K shares
Shares
+142.50K
Strike price
4.22
Held after
142.50K
Exercisable
—
2/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock142.50K shares | 2/21/2025 | A · Award | +142.50K | 4.22 | — | 142.50K |